ABCL vs. ABSI

Last updated Jun 4, 2026

ABCL (AbCellera Biologics Inc.) and ABSI (Absci Corporation) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, ABCL returned -5.56%/yr vs 46.74%/yr for ABSI. At a 0.48 correlation, their price movements are largely independent.

Performance

ABCL vs. ABSI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbCellera Biologics Inc. (ABCL) and Absci Corporation (ABSI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both investments are quite close, with ABCL having a 67.25% return and ABSI slightly higher at 70.20%.

ABCL

• 1D: -6.69%
• 1M: 24.62%
• YTD: 67.25%
• 6M: 63.90%
• 1Y: 147.62%
• 3Y*: -5.56%
• 5Y*: -26.11%
• 10Y*: —

ABSI

• 1D: -6.46%
• 1M: 5.69%
• YTD: 70.20%
• 6M: 80.55%
• 1Y: 113.67%
• 3Y*: 46.74%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ABCL vs. ABSI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ABCL AbCellera Biologics Inc.	67.25%	16.72%	-48.69%	-43.63%	-29.16%	-10.79%
ABSI Absci Corporation	70.20%	33.21%	-37.62%	100.00%	-74.39%	-62.02%

Correlation

The correlation between ABCL and ABSI is 0.57, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.57
Correlation (3Y) Calculated over the trailing 3-year period	0.53
Correlation (All Time) Calculated using the full available price history since Jul 23, 2021	0.48

The correlation between ABCL and ABSI has been stable across timeframes, ranging from 0.48 to 0.57 - a consistent structural relationship.

Fundamentals

Market Cap ABCL : $1.73B ABSI : $908.59M
EPS ABCL : -$0.48 ABSI : -$0.82
PS Ratio ABCL : 21.65 ABSI : 526.70
PB Ratio ABCL : 1.85 ABSI : 5.28
Total Revenue (TTM) ABCL : $79.21M ABSI : $1.62M
Gross Profit (TTM) ABCL : $70.89M ABSI : -$21.67M
EBITDA (TTM) ABCL : -$166.07M ABSI : -$115.23M

Return for Risk

ABCL vs. ABSI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABCL

ABCL Risk / Return Rank: 81
ABCL Sharpe Ratio Rank: 87
ABCL Sortino Ratio Rank: 84
ABCL Omega Ratio Rank: 79
ABCL Calmar Ratio Rank: 80
ABCL Martin Ratio Rank: 74

ABSI

ABSI Risk / Return Rank: 74
ABSI Sharpe Ratio Rank: 76
ABSI Sortino Ratio Rank: 76
ABSI Omega Ratio Rank: 73
ABSI Calmar Ratio Rank: 75
ABSI Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABCL vs. ABSI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and Absci Corporation (ABSI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ABCL	ABSI	Difference
Sharpe ratio: Return per unit of total volatility	1.88	1.23	+0.65
Sortino ratio: Return per unit of downside risk	2.61	2.12	+0.50
Omega ratio: Gain probability vs. loss probability	1.30	1.25	+0.05
Calmar ratio: Return relative to maximum drawdown	2.70	2.12	+0.59
Martin ratio: Return relative to average drawdown	4.94	3.89	+1.05
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ABCL vs. ABSI - Sharpe Ratio Comparison

The current ABCL Sharpe Ratio is 1.88, which is higher than the ABSI Sharpe Ratio of 1.23. The chart below compares the historical Sharpe Ratios of ABCL and ABSI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ABCL	ABSI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.88	1.23	+0.65
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.39	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.50	-0.24	-0.25

Drawdowns

ABCL vs. ABSI - Drawdown Comparison

The maximum ABCL drawdown since its inception was -96.72%, roughly equal to the maximum ABSI drawdown of -96.20%. Use the drawdown chart below to compare losses from any high point for ABCL and ABSI.

Drawdown Indicators

	ABCL	ABSI	Difference
Max Drawdown Largest peak-to-trough decline	-96.72%	-96.20%	-0.52%
Max Drawdown (1Y) Largest decline over 1 year	-54.94%	-54.00%	-0.94%
Max Drawdown (3Y) Largest decline over 3 years	-75.72%	-66.06%	-9.66%
Max Drawdown (5Y) Largest decline over 5 years	-92.64%	—	—
Current Drawdown Current decline from peak	-90.29%	-80.39%	-9.90%
Average Drawdown Average peak-to-trough decline	-83.59%	-84.80%	+1.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	30.01%	29.32%	+0.69%

Volatility

ABCL vs. ABSI - Volatility Comparison

AbCellera Biologics Inc. (ABCL) and Absci Corporation (ABSI) have volatilities of 28.65% and 28.30%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ABCL	ABSI	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.65%	28.30%	+0.35%
Volatility (6M) Calculated over the trailing 6-month period	52.34%	65.46%	-13.12%
Volatility (1Y) Calculated over the trailing 1-year period	79.56%	93.26%	-13.70%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	66.48%	96.53%	-30.05%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	70.07%	96.53%	-26.46%

Dividends

ABCL vs. ABSI - Dividend Comparison

Neither ABCL nor ABSI has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ABCL and ABSI in my portfolio?

ABCL and ABSI have a correlation of 0.57, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ABCL or ABSI?

ABCL has higher volatility (28.65%) compared to ABSI (28.30%). In terms of maximum drawdown, ABCL dropped -96.72% vs ABSI's -96.20%.

Which has better risk-adjusted returns?

ABCL currently has the higher Sharpe Ratio (1.88 vs 1.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.